Richard Francis, Teva Prescribed drugs CEO, joins ‘Cash Movers’ to debate the corporate’s quarterly earnings outcomes, drug worth negotiations, and far more.
Richard Francis, Teva Prescribed drugs CEO, joins ‘Cash Movers’ to debate the corporate’s quarterly earnings outcomes, drug worth negotiations, and far more.